Delivery Order SPE2DB20D3103-SPE2DB22FM4Y8
Award Date 2/1/22
Potential Completion Date 2/2/22
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,649.74 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,002.56 firm fixed-price delivery order is for the supply of Emtricitabine-Tenofovir 200-300mg prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award, valued at $1,319.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emtricitabine-Tenofovir 200-300 mg pharmaceutical products, with a completion date of May 10, 2022. This is a firm-fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a subsidiary of the parent company,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,285.64 fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300mg tablets, a type of prescription medication. The contract has a period of performance through March 9, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,116.81 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $12,657.86 delivery order contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, which are used to treat HIV/AIDS. The contract has a ceiling value of $12,657.86 and runs through August 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award is a delivery order between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $1,073.17, is for the supply of emtricitabine-tenofovir (200-300 mg) medications. The award is not designated with a set-aside requirement, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,588.81 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 milligram drug dosages. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to...
- The federal contract award is for the delivery of Emtricitabine-Tenofovir 200-300mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,633.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024, with a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,135.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emtricitabine-Tenofovir 200-300mg medical supplies, with a completion date of February 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...